So Long, Farewell, Auf Wiedersehen, Achoo!

Is it time to say goodbye to first generation allergy meds?  Yes, says a new report just published in Allergy.

The European expert authors, tell us that older H1 antihistamines, such as diphenhydramine and chlorpheniramine, readily available as over-the-counter treatments for allergic rhinitis may be dangerous to our health.

They have been linked with numerous health and social problems such as poor sleep patterns; reduced work performance and learning ability; aviation, car and boating accidents caused by drowsiness; suicides in teenagers and adults and even death as a result of accidental overdose in children and infants.
The report ultimately questions whether it is in the interest of public safety that they remain available as over-the-counter allergy medications.

SRxA‘s Word on Health is pleased to note that this doesn’t mean that the 27 million or more Americans with allergies are going to have to suffer.  Newer generation allergy medicines, available as nasal sprays or tablets have been shown to have fewer side effects, longer duration of action, and greater reliability and efficacy.